IBDQ Performance — iShares iBonds Dec 2025 Term Corporate ETF
Data updated: 2026-01-14
IBDQ returned +4.63% over one year to Oct 2025. Annualised returns are +5.32% over 3 years and +1.60% over 5 years. The fund trailed its Alternative category average: $100 invested three years ago grew to $117, against $179 for the category, and to $105 over one year, against $117. Volatility over the past three years was 1.54% a year. In the 12 months to Oct 2025 the fund lost a net $144.5M, and assets reached $2.74B.
IBDQ Growth of $100
What $100 invested in iShares iBonds Dec 2025 Term Corporate ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | IBDQ | Category average |
|---|---|---|
| 1 year (Nov 2024 – Oct 2025) | $105 | $117 |
| 3 years (Nov 2022 – Oct 2025) | $117 | $179 |
| 5 years (Nov 2020 – Oct 2025) | $108 | $178 |
| Since data start (Aug 2019 – Oct 2025) | $119 | $184 |
IBDQ Trailing Returns
Total returns to Oct 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +4.63% |
| 3 years (annualised) | +5.32% |
| 5 years (annualised) | +1.60% |
IBDQ Annual Returns
Calendar-year total returns of iShares iBonds Dec 2025 Term Corporate ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Oct) | +3.78% |
| 2024 | +5.23% |
| 2023 | +5.09% |
| 2022 | −5.98% |
| 2021 | −1.21% |
| 2020 | +8.25% |
| 2019 (Aug–Dec) | +3.09% |
IBDQ Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0.4% | +0.4% | +0.4% | +0.3% | +0.4% | +0.4% | +0.4% | +0.4% | +0.4% | +0.4% | — | — |
| 2024 | +0.5% | 0.0% | +0.4% | +0.2% | +0.6% | +0.4% | +0.8% | +0.6% | +0.6% | +0.3% | +0.4% | +0.4% |
| 2023 | +1.1% | −0.9% | +1.1% | +0.5% | −0.2% | −0.1% | +0.7% | +0.3% | 0.0% | +0.4% | +1.2% | +1.1% |
| 2022 | −1.4% | −0.9% | −2.0% | −1.2% | +0.9% | −1.3% | +1.4% | −1.2% | −1.9% | −0.2% | +1.7% | +0.1% |
| 2021 | −0.3% | −0.8% | −0.5% | +0.8% | +0.5% | −0.1% | +0.5% | −0.2% | −0.4% | −0.5% | −0.2% | 0.0% |
| 2020 | +1.6% | +1.1% | −5.9% | +4.5% | +2.3% | +1.6% | +1.4% | +0.3% | −0.2% | +0.1% | +0.9% | +0.6% |
| 2019 | — | — | — | — | — | — | — | +2.0% | −0.2% | +0.8% | −0.1% | +0.6% |
IBDQ Risk
Risk measures from monthly returns over Nov 2022 – Oct 2025.
- 3-year volatility (annualised): 1.54%
- 3-year Sharpe ratio: 0.53 (vs 4.5% risk-free rate)
- Best month: +1.73% (Nov 2022)
- Worst month: −0.89% (Feb 2023)
IBDQ Fund Flows
Monthly money in and out of iShares iBonds Dec 2025 Term Corporate ETF, from SEC Form N-PORT.
- 12-month net flow: −$144.5M
- 12-month gross sales (incl. reinvestments): $409.6M
- Sales ÷ redemptions: 0.74×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Oct 2025 | $65.3M | $95.6M | −$30.3M |
| Sep 2025 | $0 | $95.6M | −$95.6M |
| Aug 2025 | $0 | $70.4M | −$70.4M |
| Jul 2025 | $0 | $56.5M | −$56.5M |
| Jun 2025 | $2.5M | $76.7M | −$74.1M |
| May 2025 | $0 | $31.4M | −$31.4M |
| Apr 2025 | $0 | $89.1M | −$89.1M |
| Mar 2025 | $6.3M | $28.9M | −$22.6M |
| Feb 2025 | $22.6M | $8.8M | $13.8M |
| Jan 2025 | $52.6M | $0 | $52.6M |
| Dec 2024 | $209.0M | $1.3M | $207.7M |
| Nov 2024 | $51.4M | $0 | $51.4M |
IBDQ Assets Under Management
Net assets of iShares iBonds Dec 2025 Term Corporate ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-10-31 | $2.74B |
| 2025-07-31 | $2.94B |
| 2025-04-30 | $3.10B |
| 2025-01-31 | $3.19B |
| 2024-10-31 | $2.87B |
| 2024-07-31 | $2.70B |
| 2024-04-30 | $2.62B |
| 2024-01-31 | $2.54B |
| 2023-10-31 | $2.20B |
| 2023-07-31 | $2.11B |
| 2023-04-30 | $1.98B |
| 2023-01-31 | $1.80B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.